BioInsights - Addressing lingering safety issues for I-O product candidates in development - spotlight

IMMUNO-ONCOLOGY INSIGHTS

Addressing lingering safety issues for I-O product candidates in development

Ashok  Gupta
Guest Editor:
Ashok Gupta, MD, PhD, Global Clinical Head, Imfinzi Genitourinary Cancers and Tumor Agnostic Indications at AstraZeneca
December 2020